Efficacy and safety of a novel TKI (anlotinib) for the treatment of advanced digestive system neoplasms - a systematic review and meta-analysis
Favorite
Share
More Options
15

Open in WPS to view all 15 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
